Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

New Share Buyback Programme

17 Apr 2025 13:45

RNS Number : 5172F
B.P. Marsh & Partners PLC
17 April 2025
 

17 April 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", the "Company" or the "Group")

 

New Share Buyback Programme

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist venture capital investor in early stage financial services businesses, today announces the launch of a new share buy-back programme (the "Programme"), replacing the buyback programme announced on 11 June 2024.

 

The Company has entered into an irrevocable commitment with Singer Capital Markets to manage the Programme through a non-discretionary programme, repurchasing the Company's Ordinary Shares on its behalf, for up to a maximum aggregate consideration of £2 million, and within certain defined parameters. Singer Capital Markets will make trading decisions in relation to the buyback of Ordinary Shares independently of the Company within the programme terms and will therefore have the ability to trade during close periods.

 

Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other terms. The maximum price paid per Ordinary Share will be no more than the higher of (a) 5 per cent. above the average middle market quotations for an Ordinary Share (as derived from the AIM Appendix to the London Stock Exchange Daily Official List) for the five business days immediately prior to the day the purchase is made and (b) the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out. Under the Programme, the repurchased shares will be held in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

 

The Programme will operate in accordance with the Company's general authority to purchase a maximum of 3,723,283 Ordinary Shares (the "Authority"), granted by its shareholders at the Annual General Meeting of the Company held on 23 July 2024 (since when the Company has repurchased 93,570 Ordinary Shares pursuant to the Authority). Unless renewed sooner, the Authority will expire at the Company's next Annual General Meeting (the "2025 AGM") or, if earlier, at the close of business on 31 July 2025. The Company expects to seek shareholders' approval authorising another such general authority for a further approximate twelve months in due course (if approved a "General Authority"), subject to which the Programme would continue beyond 31 July 2025 in accordance with the renewed General Authority and the parameters set out above.

 

The purpose of the Programme is to reduce the Company's share capital. The Company confirms that it currently has no unpublished price sensitive information.

 

The Company will make further regulatory announcements in respect of repurchases of Ordinary Shares as required by the UK's version of the Market Abuse Regulation and the AIM Rules for Companies.

 

For further information, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

 

Notes to Editors:

B.P. Marsh's current portfolio contains fifteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGMDZNMGKZM
Date   Source Headline
8th Jul 202411:05 amRNSTransaction in Own Shares
4th Jul 20242:20 pmRNSTransaction in Own Shares
3rd Jul 20241:19 pmRNSTransaction in Own Shares
2nd Jul 20241:07 pmRNSTransaction in Own Shares
28th Jun 20249:20 amRNSTransaction in Own Shares
27th Jun 20244:58 pmRNSNotice of AGM & Change of Name of NOMAD and Broker
20th Jun 202410:47 amRNSTransaction in Own Shares
19th Jun 20249:17 amRNSTransaction in Own Shares
13th Jun 20242:28 pmRNSDirector/PDMR Shareholding
13th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:01 amRNSShare Buy-Back Programme
11th Jun 20247:00 amRNSFinal Results for the Year to 31 January 2024
29th May 20247:00 amRNSNotice of Results
16th Apr 202412:45 pmRNSInvestee Company Update – LEBC Holdings
12th Apr 202411:01 amRNSAward of Shares under Share Incentive Plan
9th Apr 20249:45 amRNSInvestment Update – Pantheon Specialty Limited
8th Apr 20243:07 pmRNSTransfer of Treasury Shares
27th Mar 202412:20 pmRNSInvestment – Devonshire UW Limited
25th Mar 20247:00 amRNSCompletion of Sale and Dividend Declaration
22nd Feb 202410:49 amRNSDirector/PDMR Shareholding
19th Feb 20244:05 pmRNSDirector/PDMR Shareholding
19th Feb 20247:00 amRNSTrading Update
16th Feb 20244:13 pmRNSDirector/PDMR Shareholding
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
13th Feb 20241:52 pmRNSHolding(s) in Company
9th Feb 20249:25 amRNSDirector/PDMR Shareholding
7th Feb 20243:00 pmRNSInterim Dividend Declaration
6th Feb 202412:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20242:23 pmRNSUse of Proceeds of Sale and Strategy Confirmation
4th Jan 20244:35 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:25 amRNSInvestment – Ai Marine Risk Limited
27th Dec 20237:00 amRNSCorrection - PDMR and Director Dealings
8th Dec 20235:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:23 amRNSRealisation of Investment
4th Dec 202310:58 amRNSTransaction in Own Shares
30th Nov 202312:56 pmRNSTransaction in Own Shares
29th Nov 20232:29 pmRNSTransaction in Own Shares
27th Nov 202312:48 pmRNSTransaction in Own Shares
24th Nov 20234:15 pmRNSTransaction in Own Shares
23rd Nov 20234:55 pmRNSTransaction in Own Shares
20th Nov 202312:35 pmRNSFurther Information re Share Option Plan
20th Nov 202311:44 amRNSTransaction in Own Shares
15th Nov 20235:33 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSShares Cancellation & New Share Buy-Back Programme
13th Nov 20239:42 amRNSInvestee Company Update disposal by LEBC of Aspira
20th Oct 20236:23 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSHalf-Year Results
11th Oct 20234:05 pmRNSNotice of Half Year Results
10th Oct 20237:00 amRNSCompletion of Sale of Kentro Capital Limited
2nd Oct 202312:05 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.